Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (91-100 of 470) with videos related to

Pageof 47
Sort By:
Drugs & Aging|April 9, 2019
Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with DementiaMehnaz Ahmed, Marlene Malik, Johannes Teselink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological studyMyuri Ruthirakuhan, Zahinoor Ismail, Nathan Herrmann, et al.
Biological Psychiatry|August 10, 2010
A meta-analysis of cytokines in Alzheimer's diseaseWalter Swardfager, Krista Lanctôt, Lana Rothenburg, et al.
CNS Drugs|January 10, 2022
Pharmacological Management of Apathy in DementiaLaiba Azhar, Raphael W Kusumo, Giovanni Marotta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
Biomarkers of agitation and aggression in Alzheimer's disease: A systematic reviewMyuri Ruthirakuhan, Krista L Lanctôt, Matteo Di Scipio, et al.
BMC Geriatrics|December 16, 2011
Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysisDallas P Seitz, Prakesh S Shah, Nathan Herrmann, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Apathy and Attentional Biases in Alzheimer's DiseaseSarah A Chau, Jonathan Chung, Nathan Herrmann, et al.
The Yale Journal of Biology and Medicine|March 30, 2019
Sleep and Attention in Alzheimer's DiseaseMirna Hennawy, Solomon Sabovich, Celina S Liu, et al.
Drugs & Aging|February 22, 2012
Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?Karen Levy, Krista L Lanctôt, Shale B Farber, et al.
International Journal of Geriatric Psychiatry|July 22, 2005
Antipsychotic use in the elderly: shifting trends and increasing costsMark Rapoport, Muhammad Mamdani, Kenneth I Shulman, et al.
Pageof 47

Showing results (91-100 of 470) with videos related to

Sort By:
Pageof 47
Drugs & Aging|April 9, 2019
Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with DementiaMehnaz Ahmed, Marlene Malik, Johannes Teselink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological studyMyuri Ruthirakuhan, Zahinoor Ismail, Nathan Herrmann, et al.
Biological Psychiatry|August 10, 2010
A meta-analysis of cytokines in Alzheimer's diseaseWalter Swardfager, Krista Lanctôt, Lana Rothenburg, et al.
CNS Drugs|January 10, 2022
Pharmacological Management of Apathy in DementiaLaiba Azhar, Raphael W Kusumo, Giovanni Marotta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
Biomarkers of agitation and aggression in Alzheimer's disease: A systematic reviewMyuri Ruthirakuhan, Krista L Lanctôt, Matteo Di Scipio, et al.
BMC Geriatrics|December 16, 2011
Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysisDallas P Seitz, Prakesh S Shah, Nathan Herrmann, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Apathy and Attentional Biases in Alzheimer's DiseaseSarah A Chau, Jonathan Chung, Nathan Herrmann, et al.
The Yale Journal of Biology and Medicine|March 30, 2019
Sleep and Attention in Alzheimer's DiseaseMirna Hennawy, Solomon Sabovich, Celina S Liu, et al.
Drugs & Aging|February 22, 2012
Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?Karen Levy, Krista L Lanctôt, Shale B Farber, et al.
International Journal of Geriatric Psychiatry|July 22, 2005
Antipsychotic use in the elderly: shifting trends and increasing costsMark Rapoport, Muhammad Mamdani, Kenneth I Shulman, et al.
Pageof 47